256 related articles for article (PubMed ID: 17200431)
21. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.
Dopazo C; Bilbao I; Lázaro JL; Sapisochin G; Caralt M; Blanco L; Castells L; Charco R
Transplant Proc; 2009 Apr; 41(3):1021-4. PubMed ID: 19376416
[TBL] [Abstract][Full Text] [Related]
22. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.
Lasocki A; Vote B; Fassett R; Zamir E
Ocul Immunol Inflamm; 2007; 15(4):345-6. PubMed ID: 17763133
[TBL] [Abstract][Full Text] [Related]
24. [Acute rhabdomyolysis: a case report and literature review].
Mrsić V; Nesek Adam V; Grizelj Stojcić E; Rasić Z; Smiljanić A; Turcić I
Acta Med Croatica; 2008 Jul; 62(3):317-22. PubMed ID: 18843854
[TBL] [Abstract][Full Text] [Related]
25. Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy.
Wong WM; Wai-Hung Shek T; Chan KH; Chau E; Lai KC
J Gastroenterol Hepatol; 2004 Aug; 19(8):952-3. PubMed ID: 15242511
[No Abstract] [Full Text] [Related]
26. Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
DiGregorio RV; Pasikhova Y
Pharmacotherapy; 2009 Mar; 29(3):352-6. PubMed ID: 19249953
[TBL] [Abstract][Full Text] [Related]
27. Myopathy associated with atorvastatin-ezetimibe combination therapy.
Weffald LA; Flach LA
Pharmacotherapy; 2007 Feb; 27(2):309-11. PubMed ID: 17253923
[TBL] [Abstract][Full Text] [Related]
28. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.
Butler MJ; Eccleston D; Clark DJ; Ajani AE; Andrianopoulos N; Brennan A; New G; Black A; Szto G; Reid CM; Yan BP; Shaw JA; Dart AM; Duffy SJ;
Am Heart J; 2009 May; 157(5):899-907. PubMed ID: 19376319
[TBL] [Abstract][Full Text] [Related]
29. Statin specific toxicity in organ transplant recipients: case report and review of the literature.
Bae J; Jarcho JA; Denton MD; Magee CC
J Nephrol; 2002; 15(3):317-9. PubMed ID: 12113605
[TBL] [Abstract][Full Text] [Related]
30. Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.
Martin JE; Cavanaugh TM; Trumbull L; Bass M; Weber F; Aranda-Michel J; Hanaway M; Rudich S
Clin Transplant; 2008; 22(1):113-9. PubMed ID: 18217912
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Best PJ; Steinhubl SR; Berger PB; Dasgupta A; Brennan DM; Szczech LA; Califf RM; Topol EJ;
Am Heart J; 2008 Apr; 155(4):687-93. PubMed ID: 18371477
[TBL] [Abstract][Full Text] [Related]
32. Probable statin-induced testicular pain.
Linnebur SA; Hiatt WH
Ann Pharmacother; 2007 Jan; 41(1):138-42. PubMed ID: 17200428
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity.
Ricaurte B; Guirguis A; Taylor HC; Zabriskie D
Ann Pharmacother; 2006 Apr; 40(4):753-7. PubMed ID: 16537817
[TBL] [Abstract][Full Text] [Related]
34. Combination drug products: an indication for medication reconciliation and pharmacist counseling.
Stroup J; Stephens J
J Am Pharm Assoc (2003); 2008; 48(4):541-3. PubMed ID: 18653432
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation.
Tuteja S; Pyrsopoulos NT; Wolowich WR; Khanmoradi K; Levi DM; Selvaggi G; Weisbaum G; Tzakis AG; Schiff ER
Pharmacotherapy; 2008 Sep; 28(9):1188-93. PubMed ID: 18752389
[TBL] [Abstract][Full Text] [Related]
36. Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature.
Watkins JL; Atkinson BJ; Pagliaro LC
Ann Pharmacother; 2011 Feb; 45(2):e9. PubMed ID: 21304039
[TBL] [Abstract][Full Text] [Related]
37. Acute rhabdomyolysis following administration of high-dose cyclophosphamide: case report.
Shima E; Hino M; Yamane T; Aoyama Y; Nakamae H; Yamamura R; Makita K; Sugano Y; Yasuda S; Takubo T; Ohta K; Tatsumi N
Ann Hematol; 2002 Jan; 81(1):55-6. PubMed ID: 11807638
[TBL] [Abstract][Full Text] [Related]
38. Itraconazole-induced rhabdomyolysis and acute renal failure in a heart transplant recipient treated with simvastatin and cyclosporine.
Vlahakos DV; Manginas A; Chilidou D; Zamanika C; Alivizatos PA
Transplantation; 2002 Jun; 73(12):1962-4. PubMed ID: 12131698
[TBL] [Abstract][Full Text] [Related]
39. Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist involvement.
Korzec J; Strausbaugh R; Mikolay JJ; Churchwell MD
J Am Pharm Assoc (2003); 2024; 64(3):102016. PubMed ID: 38272309
[TBL] [Abstract][Full Text] [Related]
40. Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review.
Hsiao SH; Chang HJ; Hsieh TH; Kao SM; Yeh PY; Wu TJ
J Clin Pharm Ther; 2016 Oct; 41(5):575-8. PubMed ID: 27430348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]